| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2012 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CVS HEALTH CORP COM | 40 | Q3 2023 | 5.0% |
| ISHARES U.S. CONSUMER GOODS ETF | 40 | Q3 2023 | 3.4% |
| GILEAD SCIENCES INC COM | 40 | Q3 2023 | 5.3% |
| ALTRIA GROUP INC COM | 40 | Q3 2023 | 4.2% |
| APPLE INC COM | 40 | Q3 2023 | 5.6% |
| META PLATFORMS INC CL A | 40 | Q3 2023 | 2.8% |
| BIOGEN INC COM | 40 | Q3 2023 | 3.8% |
| JOHNSON & JOHNSON COM | 40 | Q3 2023 | 2.3% |
| VISA INC COM CL A | 40 | Q3 2023 | 2.1% |
| ARES CAPITAL CORP COM | 40 | Q3 2023 | 2.3% |
View Fernwood Investment Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-03 |
| 13F-HR | 2022-02-09 |
View Fernwood Investment Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.